🇺🇸 FDA
Patent

US 7915036

Compositions comprising T cell receptors and methods of use thereof

granted A61KA61K2239/57A61K38/00

Quick answer

US patent 7915036 (Compositions comprising T cell receptors and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2239/57, A61K38/00, A61K40/11, A61K40/32